45
Participants
Start Date
October 31, 2006
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
Primovist® 0,25 mmol/ml solution for injection
intravenous bolus injection of 25 µmol/kg (=0,1 ml/kg) body weight Primovist® and blood sampling before (serum blank) and 6, 11, 21, 31, 45, 65, 95, 125 min and 3, 4, 6, 8, 12, 24 and 48 h after drug administration
MRI
lmaging of 20 slices (thickness: 3 mm; max. time of imaging 10 s) before and 0.25, 1, 2, 3, 4, 5, 7, 8, 9, 10, 20, 30, 40, 50, 60, 90 and 120 min after intravenous bolus injection of 25 µmol/kg (=0,1 ml/kg) body weight Primovist®
Department of Clinical Pharmacology at the University of Greifswald, Greifswald
University Medicine Greifswald
OTHER